Targeting activated KIT signaling for melanoma therapy.
University of California at San Francisco, San Francisco, CA.
Boris C
BC
Bastian
Rosaura
R
Esteve-Puig
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006801:Humans; D008545:Melanoma / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism; D009154:Mutation / Q000235:genetics; D011379:Prognosis; D019009:Proto-Oncogene Proteins c-kit / Q000235:genetics / Q000378:metabolism*; D015398:Signal Transduction / Q000187:drug effects*
D000970:Antineoplastic Agents; D019009:Proto-Oncogene Proteins c-kit